Erbitux (Cetuximab)
Erbitux is a chimaeric monoclonal antibody (MAb) that is specific for...
Acomplia (Rimonabant) - Investigational Agent for the Management of Obesity
Developed by Sanofi-Aventis, Acomplia (rimonabant) is a selective...
Xolair - Biological Therapy
The product of a joint development programme between Tanox, Genentech...
Exanta - Oral Direct Thrombin Inhibitor for the
Exanta (ximelagatran) is an oral Direct Thrombin Inhibitor (DTI)...
Prexige - COX-2 Inhibitor
Prexige (lumiracoxib) is an innovative COX-2 inhibitor developed by...
See all projects
Teva, Active Biotech enrol first patient in RRMS drug Phase III study
Teva Pharmaceutical Industries and Active Biotech have enrolled the...
Biogen, Sobi Phase III studies support recombinant Fc fusion proteins protection capability
Biogen Idec and Swedish Orphan Biovitrum (Sobi) have announced new data...
Biogen, Biovitrum begin paediatric trials of haemophilia A and B candidates
Biogen and Swedish Orphan Biovitrum have started two paediatric trials of...
Biogen Idec multiple sclerosis drug reports positive Phase 3 data
Biogen Idec's oral BG-12 (dimethyl fumarate) drug demonstrated safety...
Biogen Idec, Elan begins multiple sclerosis drug study
Biogen Idec and Elan Corporation are conducting a global Phase 3b...
Biogen Multiple Sclerosis Drug Meets Study Goals
Biogen has reported positive top-line results from the first of two Phase...
Russia First to Approve RRMS Drug Cladribine
The Russian Federal Service on Surveillance in Healthcare and...
Biogen and Swedish Orphan Biovitrum Advance Haemophilia Drug Trial
Biogen Idec and Swedish Orphan Biovitrum have decided to advance...
Roche and Biogen Halt Ocrelizumab Trials
Swiss firm Roche and US firm Biogen Idec have suspended the ongoing...
Biogen Kicks off Haemophilia B Trials
Biogen Idec and Swedish firm Orphan Biovitrum have begun dosing the...
See all news
Twitter
Facebook